Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.

Toronto-based Cronos Group reported first-quarter results Thursday revealing the licensed marijuana company’s losses grew from a year ago as it missed revenue expectations.

Cronos reported first-quarter revenue of 6.5 million Canadian dollars ($4.8 million) for the period ended March 31 – up 120% from the year-ago period, the company said in a news release.

The performance missed analyst estimates of CA$7 million.

The company’s red ink for the quarter rang in at CA$9 million, up from CA$1.5 million in the same quarter of 2018.

Shares of Cronos, which trades on the Nasdaq as CRON, slipped nearly 6% to $14.57 in early trading Thursday – down from the opening price of $15.76 a share.

Founded in 2013, the company cultivates and distributes medical and recreational marijuana in five provinces across Canada.

Get access to more in-depth market analysis, premium features on cannabis investing trends and monthly executive webcasts with an Investor Intelligence subscription.